Need Access?
If you are a licensed provider and would like to access the Practitioner List, or your payment statements please e-mail nlpdp@bell.ca to request a USERNAME and PASSWORD.

 
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit List update: AMGEVITA 20 MG/0.4 ML PF SYR, 40mg/0.8ml PF SYR, 40mg/0.8ml PF AUTOINJECTOR642021-Apr-19Word PDF
NIDPF Delisting - PMS-CLONAZEPAM 1 MG TABLET632021-Apr-16Word PDF
NIDPF Delisting - Proctodan-HC 10mg-20mg-10mg Suppository 622021-Apr-16Word PDF
Benefit List Updates_New Addition_Lonsurf 15mg/6.14, 20mg/8.19mg612021-Apr-16Word PDF
Benefit List update: AVSOLA 100 MG VIAL 602021-Apr-16Word PDF
Benefit List update: CYSTADROPS 3.8 mg/mL OPHTHALMIC SOLUTION592021-Apr-15Word PDF
Update: Short-Stock - Ramipril-HCTZ 5/12.5mg582021-Apr-09Word PDF
Benefit List Updates_New Addition_Erleada 60mg572021-Apr-05Word PDF
Online version of NIDPF Vol. 84 effective April 1, 2021562021-Apr-01Word PDF
Over-The-Counter Product Delistings552021-Mar-31Word PDF
Coverage Status of Teva-Cephalexin Capsules542021-Mar-26Word PDF
Coverage Status of Erythromycin Eye Ointment 5mg/g 3.5g tube DIN 02326663532021-Mar-26Word PDF
NLPDP Benefit Status Effective April 1, 2021522021-Mar-25Word PDF
NIDPF Vol. 84 Supplement Effective April 1, 2021 - Refer to Bulletin #52 for Benefit Status512021-Mar-25Word PDF
DIN 02442302 - QUINSAIR 240MG/2.4ML INHAL SOL Pricing Clarification502021-Mar-23Word PDF
Short-Stock: Alendronic Acid/Vitamin D3 70 mg/5600IU 492021-Mar-23Word PDF
Coverage Status of Solystat powder DIN 00755338 (sodium polystyrene sulfonate)482021-Mar-22Word PDF
Benefit Status Update_Criteria Update_ DORNASE ALFA (PULMOZYME 1 MG/ML AMPOULE)472021-Mar-18Word PDF
Delisting - Nabilone .25mg462021-Mar-18Word PDF
Benefit List Update: Teva-Citalopram 10mg452021-Mar-18Word PDF
Page  Go
Page 1 of 52
Document Name: Date Range: To


Document NameDateView
Coverage Status Table - March 20212021-Mar-22 PDF
Coverage Status Table - February 20212021-Feb-11 PDF
Coverage Status Table - January 20212021-Jan-21 PDF
Coverage Status Table - December 20202020-Dec-10 PDF
Coverage Status Table - November 20202020-Nov-19 PDF
Coverage Status Table - October 20202020-Oct-16 PDF
Coverage Status Table - September 20202020-Sep-22 PDF
Coverage Status Table - August 20202020-Aug-24 PDF
Coverage Status Table - July 20202020-Jul-22 PDF
Coverage Status Table - June 20202020-Jun-25 PDF
Coverage Status Table - May 20202020-May-22 PDF
Coverage Status Table - April 20202020-Apr-24 PDF
Coverage Status Table - March 20202020-Apr-02 PDF
Coverage Status Table - February 20202020-Feb-14 PDF
Coverage Status Table - January 20202020-Jan-09 PDF
Coverage Status Table - December 20192019-Dec-20 PDF
Coverage Status Table - November 20192019-Nov-22 PDF
Coverage Status Table - October 20192019-Oct-25 PDF
Coverage Status Table - September 20192019-Sep-24 PDF
Coverage Status Table - August 20192019-Aug-27 PDF
Page  Go
Page 1 of 2
Document Name: Date Range: To


Document NameDateView
Diabetic Listing - January 12, 2021 (Refer to Bulletin #9 posted on January 12, 2021)2021-Jan-12Word PDF
Diabetic Listing - May, 2020(Refer to Bulletin #77 posted on May 1, 2020)2020-May-04Word PDF
Diabetic Listing - October, 2019 (Refer to Bulletin #206 posted on October 29, 2019)2019-Oct-30Word PDF
Diabetic Listing - July, 2019 (Refer to Bulletin #132 posted on July 12, 2019)2019-Jul-12Word PDF
 
Page 1 of 1
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit List update: AMGEVITA 20 MG/0.4 ML PF SYR, 40mg/0.8ml PF SYR, 40mg/0.8ml PF AUTOINJECTOR642021-Apr-19Word PDF
Benefit List Updates_New Addition_Lonsurf 15mg/6.14, 20mg/8.19mg612021-Apr-16Word PDF
Benefit List update: AVSOLA 100 MG VIAL 602021-Apr-16Word PDF
Benefit List update: CYSTADROPS 3.8 mg/mL OPHTHALMIC SOLUTION592021-Apr-15Word PDF
Benefit List Updates_New Addition_Erleada 60mg572021-Apr-05Word PDF
Benefit Status Update_Criteria Update_ DORNASE ALFA (PULMOZYME 1 MG/ML AMPOULE)472021-Mar-18Word PDF
Benefit List Update: Teva-Citalopram 10mg452021-Mar-18Word PDF
Benefit list update: Special Authorization: TAKHZYRO 300MG/2ML PFS, 300 MG/2 ML Vial)432021-Mar-18Word PDF
Benefit list update: Special Authorization: RADICAVA 30MG/100ML INTRAVENOUS SOLUTION 412021-Mar-02Word PDF
Benefit list update: Special Authorization: ALLERJECT 0.15 mg/0.15 mL, 0.3 mg/0.3 mL402021-Mar-01Word PDF
Benefit List Update: New Additions_Special Authorization: FASENRA 30MG/ML AUTOINJECTOR342021-Feb-25Word PDF
Benefit List Update: New Additions_Special Authorization: FULPHILA 6 MG/0.6 ML SYRINGE332021-Feb-25Word PDF
Benefit list updates_New additions to Existing Category_STIVARGA 40MG tablets322021-Feb-24Word PDF
Benefit List Update: New Additions: Duodopa intestinal gel cassette232021-Jan-28Word PDF
Benefit List Update_Criteria Update_Afinitor, Nexavar, Sutent, and Votrient202021-Jan-22Word PDF
Benefit list update_New additions to an existing category_ EMERADE 0.3mg & 0.5mg 192021-Jan-20Word PDF
Benefit list updates_New additions_Special Authorization_Movapo 30mg 3ml Pen182021-Jan-20Word PDF
Benefit List Updates_New Addition_Cabometyx 20mg, 40mg, 60mg122021-Jan-18Word PDF
Benefit List Update_New Addition_Open Benefit: Xaltral and Generics1872020-Dec-31Word PDF
Benefit List Update: New Addition_ Special Authorization_MAVENCLAD 10mg tablets1842020-Dec-22Word PDF
Page  Go
Page 1 of 5
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Update: Short-Stock - Ramipril-HCTZ 5/12.5mg582021-Apr-09Word PDF
Short-Stock: Alendronic Acid/Vitamin D3 70 mg/5600IU 492021-Mar-23Word PDF
Update - Short-Stock: Cabergoline 0.5 mg422021-Mar-05Word PDF
Update - Short-Stock: Verapamil SR 120 mg372021-Feb-26Word PDF
Update - Short Stock: Clindamycin/Benzoyl Peroxide 1 Percent / 5 Percent w/w312021-Feb-19Word PDF
Update - Short-Stock: Estradiol Transdermal 75 ug Patch 302021-Feb-19Word PDF
Update - Short-Stock: Eletriptan Hydrobromide 40mg 292021-Feb-18Word PDF
Short Stock: Clindamycin/Benzoyl Peroxide 1 Percent / 5 Percent w/w272021-Feb-04Word PDF
Update - Short-Stock - Dextroamphetamine Extended Release 15mg262021-Feb-03Word PDF
Update - Short-Stock: Brimonidine Tartrate . 0.2 percent152021-Jan-19Word PDF
Update - Short-Stock: Famciclovir 250mg142021-Jan-19Word PDF
Update - Short-Stock: Irbesartan 150mg 132021-Jan-19Word PDF
Short-Stock: Atropine 1 Percent102021-Jan-12Word PDF
Short-Stock: Estradiol Transdermal 75 ug Patch 72021-Jan-12Word PDF
Short-Stock: Dextroamphetamine Extended Release 15mg62021-Jan-12Word PDF
Short Stock - Verapamil SR 120 mg52021-Jan-11Word PDF
Update: Short-Stock - Irbesartan 300 mg42021-Jan-08Word PDF
Short-Stock: Oxcarbazepine 300mg32021-Jan-05Word PDF
Short-Stock: Oxcarbazepine 150mg & 600mg22021-Jan-04Word PDF
Short-Stock: Brimonidine Tartrate . 0.2 Percent12021-Jan-04Word PDF
Page  Go
Page 1 of 9
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
NIDPF Delisting - PMS-CLONAZEPAM 1 MG TABLET632021-Apr-16Word PDF
NIDPF Delisting - Proctodan-HC 10mg-20mg-10mg Suppository 622021-Apr-16Word PDF
Online version of NIDPF Vol. 84 effective April 1, 2021562021-Apr-01Word PDF
NLPDP Benefit Status Effective April 1, 2021522021-Mar-25Word PDF
NIDPF Vol. 84 Supplement Effective April 1, 2021 - Refer to Bulletin #52 for Benefit Status512021-Mar-25Word PDF
Online version of NIDPF Vol. 83 effective March 1, 2021392021-Mar-01Word PDF
NLPDP Benefit Status Effective March 1, 2021362021-Feb-26Word PDF
NIDPF Vol. 83 Supplement Effective March 1, 2021 - Refer to Bulletin #36 for Benefit Status352021-Feb-26Word PDF
Online version of NIDPF Vol. 83 effective February 1, 2021252021-Feb-01Word PDF
NLPDP Benefit Status Effective February 1, 2021222021-Jan-25Word PDF
NIDPF Vol. 83 Supplement Effective February 1, 2021 - Refer to Bulletin #22 for Benefit Status212021-Jan-25Word PDF
NIDPF Delisting82021-Jan-12Word PDF
Online version of NIDPF Vol. 83 effective January 1, 20211892020-Dec-31Word PDF
NLPDP Benefit Status Effective January 1, 20211832020-Dec-21Word PDF
NIDPF Vol. 83 Supplement Effective January 1, 2021 - Refer to Bulletin #183 for Benefit Status1822020-Dec-21Word PDF
Online version of NIDPF Vol. 83 effective December 1, 20201762020-Dec-01Word PDF
delisting - pms-Progesterone 100mg Capsules1742020-Nov-19Word PDF
NLPDP Benefit Status Effective December 1, 20201732020-Nov-19Word PDF
NIDPF Vol. 83 Supplement Effective December 1, 2020 - Refer to Bulletin #173 for Benefit Status1722020-Nov-19Word PDF
Benefit list update: Special Authorization MICRONIZED PROGESTERONE 100mg capsules1702020-Nov-19Word PDF
Page  Go
Page 1 of 5
Document Name: Date Range: To


Document NameDateView
2021 - Payment Schedule2020-Dec-17Word PDF
2020 Payment Schedule2019-Dec-09Word PDF
 
Page 1 of 1